+44 207 394 30 90 (London)
Authoritative platform of market leaders for the exchange of knowledge and experience in the pharmaceutical field
PRODUCTION OF MEDICAL PREPARATIONS IN THE FORM OF INJECTIONS AND INFUSIONS
Operator/initiator: ROMPHARM NS
Location: Tashkent, Uzbekistan
Stage: Construction
Dates: Commissioning dates are not yet known
Investment amount: 20 million US dollars An investment project is being realised jointly with a Romanian pharmaceutical company on the construction of a new plant for the production of injectable drugs. The 1st phase of construction is underway. Contractors have not been selected yet.
PRODUCTION OF SUBSTANCES AND MEDICAL PREPARATIONS IN THE FORM OF PILLS, CAPSULES, INJECTIONS (3 PHASES)
Operator/initiator: Cadila MEDICAL PREPARATIONS Uzbekistan LLC
Location: Andijan region, Andijan district, Uzbekistan
Dates: Commissioning: phase 1 – November 2023; phase 2 – October 2024; phase 3 – November 2024
Investment amount: 50 million US dollars
Indian company Cadila MEDICAL PREPARATIONS Ltd. has signed an investment agreement with the Ministry of Investment and Foreign Trade of Uzbekistan on the establishment of the plant on the production of pharmaceutical products on the territory of the Andijan-Pharm FEZ. According to the information provided, it is expected to: attract direct foreign investments in the amount of $50 million in 2020-2025 with the allocation of at least $10 million in 2020-2021 to execute the first phase of the project; generate 400 new job opportunities; organise a modern system of production and quality management of pharmaceutical products that meets international standards. 30 names of medical preparations and medical devices produced by the company will be registered in an accelerated procedure without charging for a registration certificate.
CONSTRUCTION OF PRODUCTION FACILITIES FOR TABLETS, CAPSULES, INJECTABLES, INFUSION PREPARATIONS, SUSPENSIONS, SYRUPS AND SOLUTIONS
Operator/initiator: LAFZ
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Dates: The first phase is due to be realised in 2026
The purpose of this project is the organisation of the modern pharmaceutical complex on the issue of pharmaceutical products in the amount of 22,699.4 thousand packages annually. Construction will be carried out in three phases.
PRODUCTION AND FRACTIONATION OF IMMUNE CELL ONCOLOGICAL AND STERILE DRUG PRODUCTS, BLOOD PLASMA PROCESSING (PHASE I)
Operator/initiator: Haematech
Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park
Stage: Requires development and approval of predesign and design documentation
Dates: Feasibility study development period: Q1 2023. Execution period: 2024
Investment amount: Expected project cost: 45 million US dollars
ESTABLISHMENT OF THE TASHKENT PHARMA PARK INNOVATIVE R&D PHARMACEUTICAL CLUSTER (PHASE 1)
Operator/initiator: Agency for the Development of the Pharmaceutical Industry of the Republic of Uzbekistan
Location: Tashkent region, Zangiatinsky district, Uzbekistan
Stage: Construction and commissioning of the administrative buildings of the Pharmaceutical Safety Centre and Development Directorate
Dates: Phase 1 is scheduled to be commissioned in November 2027
Investment amount: 130.2 million US dollars
The project is realised in order to stimulate the comprehensive development of the pharmaceutical industry in the country, including by expanding the range of pharmaceuticals produced, conducting research and development, and training personnel in the field of pharmaceuticals qualified in accordance with international educational standards. Financing of the project is provided by preferential funds of the EDCF Fund of the Eximbank of Korea, the Fund for Reconstruction and Development of the Republic of Uzbekistan, the Fund for Support and Development of the Pharmaceutical Industry and foreign direct investment. The modular structure of the cluster with a total area of 50 hectares involves the establishment of industrial, academic, research, clinical and preclinical sectors. The cluster will host production sites of leading pharmaceutical companies producing innovative medical products, medical devices and equipment, a multi-disciplinary research university and its components, research centres, a state centre of expertise of pharmaceutical products, a data centre and other necessary infrastructure.
PRODUCTION OF MEDICAL PREPARATIONS: ONCOLOGICAL PREPARATIONS
Operator/initiator: HIGHLAND PHARM
Location: Zomin-Pharm FAZ, Zaamin district, Jizzak region, Uzbekistan
Stage: Preparing for construction
Dates: End of 2024
Investment amount: 150 million US dollars
HIGHLAND PHARM plans to build new facilities: it acquires a building and equipment to organise the production of an oncological preparations. In the near future, construction will be commenced in the Zomin-Pharm FEZ.
